Literature DB >> 17629961

Conformational complexity of G-protein-coupled receptors.

Brian K Kobilka1, Xavier Deupi.   

Abstract

G-protein-coupled receptors (GPCRs) are remarkably versatile signaling molecules. Members of this large family of membrane proteins respond to structurally diverse ligands and mediate most transmembrane signal transduction in response to hormones and neurotransmitters, and in response to the senses of sight, smell and taste. Individual GPCRs can signal through several G-protein subtypes and through G-protein-independent pathways, often in a ligand-specific manner. This functional plasticity can be attributed to structural flexibility of GPCRs and the ability of ligands to induce or to stabilize ligand-specific conformations. Here, we review what has been learned about the dynamic nature of the structure and mechanism of GPCR activation, primarily focusing on spectroscopic studies of purified human beta2 adrenergic receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17629961     DOI: 10.1016/j.tips.2007.06.003

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  277 in total

Review 1.  Serotonin receptor signaling and regulation via β-arrestins.

Authors:  Laura M Bohn; Cullen L Schmid
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-07       Impact factor: 8.250

2.  Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.

Authors:  Cullen L Schmid; Laura M Bohn
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

3.  Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and function.

Authors:  Cassandra Koole; Denise Wootten; John Simms; Emilia E Savage; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

4.  Structural basis for μ-opioid receptor binding and activation.

Authors:  Adrian W R Serohijos; Shuangye Yin; Feng Ding; Josee Gauthier; Dustin G Gibson; William Maixner; Nikolay V Dokholyan; Luda Diatchenko
Journal:  Structure       Date:  2011-11-09       Impact factor: 5.006

5.  Critical features for biosynthesis, stability, and functionality of a G protein-coupled receptor uncovered by all-versus-all mutations.

Authors:  Karola M Schlinkmann; Annemarie Honegger; Esin Türeci; Keith E Robison; Daša Lipovšek; Andreas Plückthun
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

6.  Two naturally occurring mutations in the type 1 melanin-concentrating hormone receptor abolish agonist-induced signaling.

Authors:  Carmit Goldstein; Jonathan C Schroeder; Jean-Philippe Fortin; Jennifer M Goss; Scott E Schaus; Martin Beinborn; Alan S Kopin
Journal:  J Pharmacol Exp Ther       Date:  2010-09-10       Impact factor: 4.030

Review 7.  On the expanding terminology in the GPCR field: the meaning of receptor mosaics and receptor heteromers.

Authors:  Luigi F Agnati; Diego Guidolin; Jean Pierre Vilardaga; Francisco Ciruela; Kjell Fuxe
Journal:  J Recept Signal Transduct Res       Date:  2010-10       Impact factor: 2.092

8.  Structural and dynamic effects of cholesterol at preferred sites of interaction with rhodopsin identified from microsecond length molecular dynamics simulations.

Authors:  George Khelashvili; Alan Grossfield; Scott E Feller; Michael C Pitman; Harel Weinstein
Journal:  Proteins       Date:  2009-08-01

9.  β1-adrenergic receptor antagonists signal via PDE4 translocation.

Authors:  Wito Richter; Delphine Mika; Elise Blanchard; Peter Day; Marco Conti
Journal:  EMBO Rep       Date:  2013-02-05       Impact factor: 8.807

10.  Differential effects of the Gβ5-RGS7 complex on muscarinic M3 receptor-induced Ca2+ influx and release.

Authors:  Darla Karpinsky-Semper; Claude-Henry Volmar; Shaun P Brothers; Vladlen Z Slepak
Journal:  Mol Pharmacol       Date:  2014-02-28       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.